Clinical Supply Blockchain Working Group led by Pfizer and Biogen completes proof-of-concept project

For nearly two years, the Clinical Supply Blockchain Working Group (CSBWG) has been working in stealth mode, said Ben Taylor, CEO of LedgerDomain, the vendor which provided the blockchain-powered platform for the group’s recent proof-of-concept project.

The iOS-based application, KitChain, is designed to fit into the clinical trial supply chain workflow, providing an immutable digital record for inventory and event tracking. It is built on top of Hyperledger Fabric, an open-source Linux Foundation project, and enables users to securely send messages between shippers, recipients, and third parties.

“Blockchain gives everybody only the fields that they need to do their job – they are in the dark on the other topics,”​ Taylor told us. “As the technology vendor, we operate on a ‘lights out’ basis … we’re just making sure that all the messages are going back and forth the way they are supposed to.”

The CSBWG – made up of representatives from sponsors, CMOs, CROs, academic sites, and one courier – tested the application earlier this year in an advance ship notification (ASN) and ‘proof-of-delivery’ use case.

The group spun out of an open-invitation workshop at the Pfizer Blockchain Center of Excellence chaired by Munther Baara, head of new clinical paradigm at the NY-headquartered pharma company. Co-chairs include Chad Sklodosky, director, digital supply chain center of excellence, Pfizer, and Imran Shakur, senior manager, clinical planning and operations, Biogen.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.